Caption Management, LLC Axsome Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $2.76 Million - $3.35 Million	35,000 New	35,000 $3.14 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $2.67 Million - $3.76 Million	38,500 New	38,500 $3.07 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $1.2 Million - $1.43 Million	-17,400 Reduced 63.27%	10,100 $705,000
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $146,025 - $225,875	-2,500 Reduced 8.33%	27,500 $1.98 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $291,950 - $375,000	-5,000 Reduced 14.29%	30,000 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $1.4 Million - $2.79 Million	35,000 New	35,000 $2.7 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $3.42 Million - $7.36 Million	157,500 Added 420.0%	195,000 $7.47 Million
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $59,250 - $103,475	-2,500 Reduced 6.25%	37,500 $1.55 Million
Q4 2021 Feb 11, 2022	BUY	$30.7 - $43.36 $1.23 Million - $1.73 Million	40,000 New	40,000 $1.51 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $872,725 - $1.73 Million	-17,500 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $1.55 Million - $3.8 Million	-37,500 Reduced 68.18%	17,500 $1.03 Million
Q4 2019 Feb 13, 2020	SELL	$16.71 - $106.24 $3.77 Million - $23.9 Million	-225,400 Reduced 80.39%	55,000 $5.68 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $4.36 Million - $6.28 Million	215,400 Added 331.38%	280,400 $5.68 Million
Q2 2019 Aug 13, 2019	SELL	$13.46 - $25.75 $302,850 - $579,375	-22,500 Reduced 25.71%	65,000 $1.67 Million
Q1 2019 May 14, 2019	BUY	$2.63 - $16.34 $230,125 - $1.43 Million	87,500 New	87,500 $1.25 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account